On June 1, 2022 Ipsen (Euronext: IPN; ADR: IPSEY) reported that it has appointed an investment-services provider to purchase 125,000 Ipsen S.A. shares, or about 0.15% of the share capital, over a maximum period of three months (Press release, Ipsen, JUN 1, 2022, View Source [SID1234615290]). The shares purchased under this agreement will be allocated mainly to cover its employee free share-allocation plan.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This program is made pursuant to the authorization granted by the Combined Shareholders’ meeting, held on May 24th, 2022.